pentoxifylline has been researched along with Chronic Disease in 98 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline added to losartan therapy for 1 year decreased proteinuria in patients with CKD stages 3 to 5." | 9.13 | Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial. ( Chen, YM; Chiang, WC; Lin, SL; Tsai, TJ; Wu, KD, 2008) |
| "The study fails to demonstrate efficacy of dl-alpha tocopheryl acetate plus pentoxifylline in patients with arm lymphoedema following axillary surgery and lymphatic radiotherapy, nor does it suggest any benefits of these drugs in radiation-induced induration (fibrosis) in the breast, chest wall, pectoral fold, axilla or supraclavicular fossa." | 9.11 | Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. ( Cornes, P; Earl, J; Gothard, L; Hall, E; MacLaren, J; Mortimer, P; Peacock, J; Peckitt, C; Woods, M; Yarnold, J, 2004) |
| " To test this hypothesis, we studied pentoxifylline, a compound that inhibits tumor necrosis factor alpha transcription and its stimulatory effect on polymorphonuclear neutrophils, in patients with CF who had chronic Pseudomonas bronchitis." | 9.07 | Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: preliminary observations. ( Aronoff, SC; Carpenter, LS; Novick, WJ; Quinn, FJ, 1994) |
| "A double-blind, placebo-controlled study was carried out in 12 patients suffering from chronic venous insufficiency and persistent leg ulcers to assess the efficacy of pentoxifylline treatment as an adjunct to compression bandaging in the conservative management of venous leg ulcers." | 9.07 | Pentoxifylline in the treatment of venous leg ulcers. ( Barbarino, C, 1992) |
| "Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo)." | 9.06 | Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. ( Ehrly, AM; Saeger-Lorenz, K, 1987) |
| "The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD)." | 9.06 | Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. ( Cobert, BL; Cohn, JB; Crowder, JE; Hryniewicki, SW; Morgan, DL; Piccirillo, RT; Savitsky, JP; Slywka, J; Wilcox, CS, 1989) |
| "To assess the effects of pentoxifylline, which has anti-inflammatory effects, in subfertile, premenopausal women for the management of endometriosis." | 8.88 | Pentoxifylline for endometriosis. ( Clarke, J; Li, Y; Lu, D; Shi, G; Song, H, 2012) |
| "The influence of vinpocetine, pentoxifylline and enalapril on endothelium functions has been studied in a group of in 172 patients with chronic brain ischemia." | 7.77 | [Endothelium-protective effects of vinpocetine, pentoxifylline and enalapril in patients with chronic brain ischemia]. ( Alifirova, VM; Vaizova, OE; Vengerovsky, AI, 2011) |
| "The short-term effects of pentoxifylline (PTX) on granulomatous lesions during Schistosoma mansoni infection in Swiss mice were evaluated." | 7.76 | Effects of pentoxifylline during Schistosoma mansoni infection in Swiss mice: an analysis of worm burden, fecundity and liver histopathology. ( Freitas, RM; Mati, VL; Melo, AL, 2010) |
| "A 58-year-old black man with leg ulcers of 43 years duration responded to pentoxifylline 400 mg tid in 8 months." | 7.68 | Treatment of sickle cell leg ulcers with pentoxifylline. ( Frost, ML; Treadwell, P, 1990) |
| "Decreasing proteinuria is the mainstay of therapy in order to delay the progression of CKD." | 6.47 | A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria. ( Abdollahi, M; Badri, S; Dashti-Khavidaki, S; Lessan-Pezeshki, M, 2011) |
| "Pentoxifylline is a useful inhibitor of TNF-alpha production, thus resembling anti-inflammatory corticosteroids." | 5.32 | Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs. ( Whitehouse, MW, 2004) |
| "Treatment with pentoxifylline was effective." | 5.29 | Chronic balanitis with palisading granuloma: an atypical genital localization of necrobiosis lipoidica responsive to pentoxifylline. ( España, A; Quintanilla, E; Redondo, P; Robledo, A; Sánchez-Yus, E; Serna, MJ, 1994) |
| "Pentoxifylline added to losartan therapy for 1 year decreased proteinuria in patients with CKD stages 3 to 5." | 5.13 | Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial. ( Chen, YM; Chiang, WC; Lin, SL; Tsai, TJ; Wu, KD, 2008) |
| "The study fails to demonstrate efficacy of dl-alpha tocopheryl acetate plus pentoxifylline in patients with arm lymphoedema following axillary surgery and lymphatic radiotherapy, nor does it suggest any benefits of these drugs in radiation-induced induration (fibrosis) in the breast, chest wall, pectoral fold, axilla or supraclavicular fossa." | 5.11 | Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. ( Cornes, P; Earl, J; Gothard, L; Hall, E; MacLaren, J; Mortimer, P; Peacock, J; Peckitt, C; Woods, M; Yarnold, J, 2004) |
| " To test this hypothesis, we studied pentoxifylline, a compound that inhibits tumor necrosis factor alpha transcription and its stimulatory effect on polymorphonuclear neutrophils, in patients with CF who had chronic Pseudomonas bronchitis." | 5.07 | Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: preliminary observations. ( Aronoff, SC; Carpenter, LS; Novick, WJ; Quinn, FJ, 1994) |
| "A double-blind, placebo-controlled study was carried out in 12 patients suffering from chronic venous insufficiency and persistent leg ulcers to assess the efficacy of pentoxifylline treatment as an adjunct to compression bandaging in the conservative management of venous leg ulcers." | 5.07 | Pentoxifylline in the treatment of venous leg ulcers. ( Barbarino, C, 1992) |
| "The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD)." | 5.06 | Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. ( Cobert, BL; Cohn, JB; Crowder, JE; Hryniewicki, SW; Morgan, DL; Piccirillo, RT; Savitsky, JP; Slywka, J; Wilcox, CS, 1989) |
| "Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo)." | 5.06 | Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. ( Ehrly, AM; Saeger-Lorenz, K, 1987) |
| "To assess the effects of pentoxifylline, which has anti-inflammatory effects, in subfertile, premenopausal women for the management of endometriosis." | 4.88 | Pentoxifylline for endometriosis. ( Clarke, J; Li, Y; Lu, D; Shi, G; Song, H, 2012) |
| "The influence of vinpocetine, pentoxifylline and enalapril on endothelium functions has been studied in a group of in 172 patients with chronic brain ischemia." | 3.77 | [Endothelium-protective effects of vinpocetine, pentoxifylline and enalapril in patients with chronic brain ischemia]. ( Alifirova, VM; Vaizova, OE; Vengerovsky, AI, 2011) |
| "The short-term effects of pentoxifylline (PTX) on granulomatous lesions during Schistosoma mansoni infection in Swiss mice were evaluated." | 3.76 | Effects of pentoxifylline during Schistosoma mansoni infection in Swiss mice: an analysis of worm burden, fecundity and liver histopathology. ( Freitas, RM; Mati, VL; Melo, AL, 2010) |
| "From 2001 to 2006, we performed a retrospective study of patients suffering from chronic unilateral or bilateral tinnitus that was previously ineffectively treated by oral drugs [betahistine (Betaserc), extract of Ginkgo biloba (EGb 761), tanakan (Tebokan), and cinnarizine-dimenhydrinate (Arlevert), singly or in combination]." | 3.74 | Multimodal therapy for chronic tinnitus. ( Achiemere, G; Alpini, D; Hahn, A; Klement, V; Radkova, L; Strouhal, J, 2008) |
| "We investigated the ability of pentoxifylline, a drug with hemorheological actions known to block tumor necrosis factor-alpha (TNF-alpha) release, to modulate whole-body protein kinetics in undialyzed patients with chronic uremia." | 3.71 | Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. ( Biolo, G; Bosutti, A; Ciocchi, B; Guarnieri, G; Situlin, R; Toigo, G, 2002) |
| "A 58-year-old black man with leg ulcers of 43 years duration responded to pentoxifylline 400 mg tid in 8 months." | 3.68 | Treatment of sickle cell leg ulcers with pentoxifylline. ( Frost, ML; Treadwell, P, 1990) |
| "The effect of combined use of pentoxifylline and solcoseryl was studied in 35 patients with chronic pancreatitis." | 3.67 | [Trial of the combined use of trental and solcoseryl in treating patients with chronic pancreatitis]. ( Solov'eva, NE; Trusov, VV; Vakhrushev, IaM, 1988) |
| "Treatment with pentoxifylline reduced circulating IL-6 (6." | 2.75 | Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease. ( Ferrari, P; Mallon, D; Olynyk, JK; Trinder, D, 2010) |
| "Proteinuria was not different between the pentoxifylline and placebo groups at baseline, 6 months, or 1 year." | 2.74 | Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial. ( Aboudara, MC; Cushner, HM; Olson, SW; Perkins, RM; Uy, AL; Yuan, CM, 2009) |
| "Sixteen Crohn's disease patients received oxpentifylline 400 mg four times a day in a four week open label study." | 2.68 | Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease. ( Bauditz, J; Haemling, J; Lochs, H; Ortner, M; Raedler, A; Schreiber, S, 1997) |
| "Decreasing proteinuria is the mainstay of therapy in order to delay the progression of CKD." | 2.47 | A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria. ( Abdollahi, M; Badri, S; Dashti-Khavidaki, S; Lessan-Pezeshki, M, 2011) |
| "Radiation enteritis is a severe problem in patients receiving irradiation of the abdomen or pelvis in the course of cancer treatment." | 2.44 | Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review. ( Böcker, U; Singer, MV; Wenz, F; Zimmerer, T, 2008) |
| "Venous ulcers affect approximately 1% of the world's population, increasing healthcare expenditures and decreasing quality of life." | 2.43 | Venous ulcers: pathophysiology and treatment options. ( Eaglstein, WH; Falabella, A; Kirsner, RS; Trent, JT, 2005) |
| "Classification of tinnitus is oriented to the duration of symptoms and their severity, the latter taking into account the victim's distress both at work and during leisure time." | 2.42 | [Tinnitus--classification, causes, diagnosis, treatment and prognosis]. ( Koester, M; Storck, C; Zorowka, P, 2004) |
| "Chronic venous insufficiency is frequent and burdened with potentially serious consequences." | 2.38 | [Conservative therapy of chronic venous insufficiency]. ( Ernst, E; Saradeth, T, 1992) |
| " We investigated the effect of chronic administration (2 weeks) of imipramine (20 mg/kg/day) and pentoxifylline (50 mg/kg/day) on behavioral, aortic histological abnormalities, and level of circulating endothelial progenitor cells (CEPCs) in peripheral blood of male Wistar rats exposed to chronic mild stress (CMS) and high-fat diet." | 1.51 | Pentoxifylline ameliorates chronic stress/high-fat diet-induced vascular wall disease: the role of circulating endothelial progenitor cells. ( Abdel-Tawab, AM; Aboul-Fotouh, S; Farrag, KA; Habib, MZ; Labib, JMW; Mekawy, MAEA, 2019) |
| "Pyoderma gangrenosum is most commonly treated with immunosuppressants or anti-inflammatory agents and is often worsened by surgical procedures due to the presence of pathergy." | 1.48 | Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid. ( Gordon, C; Hizon, BJ; Mota, JA; Nahm, WJ; Rojas, S, 2018) |
| "A method for the treatment of chronic sensorineural hearing loss (CSNHL) is proposed that includes administration of trental followed by intravenous laser irradiation of blood (IVLBI)." | 1.37 | [Intravenous laser irradiation of blood for the combined treatment of patients presenting with chronic sensorineural hearing loss]. ( , 2011) |
| "Pentoxifylline is a useful inhibitor of TNF-alpha production, thus resembling anti-inflammatory corticosteroids." | 1.32 | Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs. ( Whitehouse, MW, 2004) |
| "Treatment with pentoxifylline was effective." | 1.29 | Chronic balanitis with palisading granuloma: an atypical genital localization of necrobiosis lipoidica responsive to pentoxifylline. ( España, A; Quintanilla, E; Redondo, P; Robledo, A; Sánchez-Yus, E; Serna, MJ, 1994) |
| "Oral treatment with pentoxifylline 400 mg t." | 1.28 | Intractable chronic furunculosis: prevention of recurrences with pentoxifylline. ( Wahba-Yahav, AV, 1992) |
| "Pentoxifylline was administered orally at a dose of 1200 mg/day over a period of 30 days (eight patients) or by intravenous infusion of 100 ml saline containing 400 mg of the drug in 1 hour (three patients)." | 1.26 | Effect of pentoxifylline on cerebral blood flow in patients with chronic cerebrovascular disease. ( Battistini, N; Nardini, M; Passero, S, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (29.59) | 18.7374 |
| 1990's | 23 (23.47) | 18.2507 |
| 2000's | 33 (33.67) | 29.6817 |
| 2010's | 13 (13.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Procházková, K | 1 |
| Šejna, I | 1 |
| Skutil, J | 1 |
| Hahn, A | 2 |
| Nahm, WJ | 1 |
| Mota, JA | 1 |
| Rojas, S | 1 |
| Hizon, BJ | 1 |
| Gordon, C | 1 |
| Labib, JMW | 1 |
| Aboul-Fotouh, S | 1 |
| Habib, MZ | 1 |
| Mekawy, MAEA | 1 |
| Farrag, KA | 1 |
| Abdel-Tawab, AM | 1 |
| Radkova, L | 1 |
| Achiemere, G | 1 |
| Klement, V | 1 |
| Alpini, D | 1 |
| Strouhal, J | 1 |
| Lin, SL | 1 |
| Chen, YM | 1 |
| Chiang, WC | 1 |
| Wu, KD | 1 |
| Tsai, TJ | 1 |
| Renke, M | 1 |
| Rutkowski, P | 1 |
| Tylicki, L | 1 |
| Zietkiewicz, M | 1 |
| Larczyński, W | 1 |
| Rutkowski, B | 1 |
| Fu, M | 1 |
| Shaw, SM | 1 |
| Shah, MK | 1 |
| Williams, SG | 1 |
| Fildes, JE | 1 |
| Perkins, RM | 1 |
| Aboudara, MC | 1 |
| Uy, AL | 1 |
| Olson, SW | 1 |
| Cushner, HM | 1 |
| Yuan, CM | 1 |
| Silverberg, DS | 1 |
| Wexler, D | 1 |
| Iaina, A | 1 |
| Schwartz, D | 1 |
| Safarinejad, MR | 1 |
| Asgari, MA | 1 |
| Hosseini, SY | 1 |
| Dadkhah, F | 1 |
| Nowak, Ł | 1 |
| Zurowski, D | 1 |
| Garlicki, J | 1 |
| Thor, PJ | 1 |
| Mati, VL | 1 |
| Freitas, RM | 1 |
| Melo, AL | 1 |
| Ferrari, P | 1 |
| Mallon, D | 1 |
| Trinder, D | 1 |
| Olynyk, JK | 1 |
| Shah, SV | 1 |
| Gohel, MS | 1 |
| Davies, AH | 1 |
| Word, R | 1 |
| Badri, S | 1 |
| Dashti-Khavidaki, S | 1 |
| Lessan-Pezeshki, M | 1 |
| Abdollahi, M | 1 |
| Vaizova, OE | 1 |
| Vengerovsky, AI | 1 |
| Alifirova, VM | 1 |
| Lu, D | 1 |
| Song, H | 1 |
| Li, Y | 1 |
| Clarke, J | 1 |
| Shi, G | 1 |
| Patole, S | 1 |
| Vijayakumar, P | 1 |
| Jog, S | 1 |
| Biolo, G | 1 |
| Ciocchi, B | 1 |
| Bosutti, A | 1 |
| Situlin, R | 1 |
| Toigo, G | 1 |
| Guarnieri, G | 1 |
| Coleridge Smith, PD | 1 |
| Michetti, C | 1 |
| Coimbra, R | 1 |
| Hoyt, DB | 1 |
| Loomis, W | 1 |
| Junger, W | 1 |
| Wolf, P | 1 |
| Mohan, PV | 1 |
| Tarnow-Mordi, W | 1 |
| Stenson, B | 1 |
| Brocklehurst, P | 1 |
| Haque, K | 1 |
| Cavendish, V | 1 |
| Cust, A | 1 |
| Moulder, JE | 1 |
| Nessler, J | 1 |
| Skrzypek, A | 1 |
| Lauterbach, R | 2 |
| Pawlik, D | 1 |
| Zembala, M | 1 |
| Szymura-Oleksiak, J | 1 |
| Lisowska-Miszczyk, I | 1 |
| Kowalczyk, D | 1 |
| Bury, J | 1 |
| Georges, C | 1 |
| Lefaix, JL | 1 |
| Delanian, S | 1 |
| Whitehouse, MW | 1 |
| Gothard, L | 1 |
| Cornes, P | 1 |
| Earl, J | 1 |
| Hall, E | 1 |
| MacLaren, J | 1 |
| Mortimer, P | 1 |
| Peacock, J | 1 |
| Peckitt, C | 1 |
| Woods, M | 1 |
| Yarnold, J | 1 |
| Alekhin, DI | 1 |
| Fokin, AN | 1 |
| Trent, JT | 1 |
| Falabella, A | 1 |
| Eaglstein, WH | 1 |
| Kirsner, RS | 1 |
| Ferreira, SH | 1 |
| Koshkin, VM | 2 |
| Iglesias, CP | 1 |
| Claxton, K | 1 |
| Buell, C | 1 |
| Tobinick, E | 1 |
| Lamp, K | 1 |
| Marston, W | 1 |
| Gorbunov, AA | 1 |
| Zaporozhchenko, BS | 1 |
| Sage, E | 1 |
| Mercier, O | 1 |
| Van den Eyden, F | 1 |
| de Perrot, M | 1 |
| Barlier-Mur, AM | 1 |
| Dartevelle, P | 1 |
| Eddahibi, S | 1 |
| Herve, P | 1 |
| Fadel, E | 1 |
| Koester, M | 1 |
| Storck, C | 1 |
| Zorowka, P | 1 |
| Zimmerer, T | 1 |
| Böcker, U | 1 |
| Wenz, F | 1 |
| Singer, MV | 1 |
| Pilla, G | 1 |
| Ciaponi, A | 1 |
| Migliavacca, A | 1 |
| Bonora, C | 1 |
| Rakhmatov, AB | 1 |
| Ibragimov, ShI | 1 |
| Angelkort, B | 6 |
| Kiesewetter, H | 1 |
| Accetto, B | 1 |
| Porter, JM | 1 |
| Cutler, BS | 1 |
| Lee, BY | 1 |
| Reich, T | 1 |
| Reichle, FA | 1 |
| Scogin, JT | 1 |
| Strandness, DE | 1 |
| Shtok, VN | 1 |
| Fedorova, NV | 1 |
| Gadanova, IV | 1 |
| Passero, S | 1 |
| Nardini, M | 1 |
| Battistini, N | 1 |
| Yawalkar, N | 1 |
| Hunziker, T | 1 |
| Braathen, LR | 1 |
| Marci, M | 1 |
| Albiani, B | 1 |
| Ricci, M | 1 |
| Russo, F | 1 |
| Eninia, GI | 1 |
| Purinia, IV | 1 |
| Timofeeva, TN | 1 |
| Aronoff, SC | 1 |
| Quinn, FJ | 1 |
| Carpenter, LS | 1 |
| Novick, WJ | 1 |
| Damirov, MM | 1 |
| Kulakov, VI | 1 |
| Bakuleva, LP | 1 |
| Shabanov, AM | 1 |
| Sarkisov, SE | 1 |
| Sliusar', NN | 1 |
| España, A | 1 |
| Sánchez-Yus, E | 1 |
| Serna, MJ | 1 |
| Redondo, P | 1 |
| Robledo, A | 1 |
| Quintanilla, E | 1 |
| Johnson, WC | 1 |
| Watkins, MT | 1 |
| Hamilton, J | 1 |
| Baldwin, D | 1 |
| Walker, N | 1 |
| Ramani, A | 1 |
| Kundaje, GN | 1 |
| Nayak, MN | 1 |
| Bogdanets, LI | 1 |
| Makarova, LD | 1 |
| Shumskiĭ, AV | 1 |
| Bauditz, J | 1 |
| Haemling, J | 1 |
| Ortner, M | 1 |
| Lochs, H | 1 |
| Raedler, A | 1 |
| Schreiber, S | 1 |
| Shor, NA | 1 |
| Helunenko, AM | 1 |
| Petrunia, AM | 1 |
| Zelenyĭ, II | 1 |
| Franks, PJ | 1 |
| Bosanquet, N | 1 |
| Brown, D | 1 |
| Straub, J | 1 |
| Harper, DR | 1 |
| Ruckley, CV | 1 |
| Turner, J | 1 |
| Frank, AA | 1 |
| Brooks, JV | 1 |
| Marietta, PM | 1 |
| Orme, IM | 1 |
| Raetsch, C | 1 |
| Jia, JD | 1 |
| Boigk, G | 1 |
| Bauer, M | 1 |
| Hahn, EG | 1 |
| Riecken, EO | 1 |
| Schuppan, D | 1 |
| Koczorek, M | 1 |
| Schulz, CE | 1 |
| Richter, W | 1 |
| Naujoks, J | 1 |
| Harwart, D | 1 |
| Koppenhagen, K | 1 |
| Wenig, HG | 1 |
| Gerzić, Z | 1 |
| Dukić, V | 1 |
| Milicević, M | 1 |
| Doppelfeld, E | 1 |
| Störmer, B | 1 |
| Kleinschmidt, K | 1 |
| Loose, D | 1 |
| Kremer, K | 1 |
| Blume, J | 1 |
| Rùhlmann, KU | 1 |
| de la Haye, R | 1 |
| Rettig, K | 1 |
| Wahba-Yahav, AV | 2 |
| Rumiantsev, ISh | 1 |
| Kaznacheeva, IG | 1 |
| Abdiadilova, LV | 1 |
| Kozlov, VV | 1 |
| Ernst, E | 1 |
| Saradeth, T | 1 |
| Barbarino, C | 1 |
| Brenman, SA | 1 |
| Frost, ML | 1 |
| Treadwell, P | 1 |
| Petrova, GA | 1 |
| Levin, GIa | 1 |
| Crowder, JE | 1 |
| Cohn, JB | 1 |
| Savitsky, JP | 1 |
| Morgan, DL | 1 |
| Slywka, J | 1 |
| Cobert, BL | 1 |
| Hryniewicki, SW | 1 |
| Piccirillo, RT | 1 |
| Wilcox, CS | 1 |
| Trübestein, G | 1 |
| von Bary, S | 1 |
| Breddin, K | 1 |
| Diehm, C | 1 |
| Gruss, JD | 1 |
| Heinrich, H | 1 |
| Horsch, S | 1 |
| Kriessmann, A | 1 |
| Maass, U | 1 |
| Martin, M | 1 |
| Tesi, M | 1 |
| Bronchi, GF | 1 |
| Carini, A | 1 |
| Karavassili, M | 1 |
| Nazarova, KhI | 1 |
| Hartmann, A | 1 |
| Tsuda, Y | 1 |
| Vakhrushev, IaM | 1 |
| Trusov, VV | 1 |
| Solov'eva, NE | 1 |
| Ehrly, AM | 1 |
| Saeger-Lorenz, K | 1 |
| Shoĭkhet, IN | 1 |
| Treĭvish, VS | 1 |
| Novikova, NN | 1 |
| Spürk, P | 1 |
| Habbaba, A | 1 |
| Mähder, M | 1 |
| Atroshchenko, ES | 1 |
| Dvorkin, SB | 1 |
| Chernookiĭ, GP | 1 |
| Nuzov, BG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients: a Pilot Randomized, Placebo-controlled, Double-blind Trial.[NCT00285298] | Phase 3 | 39 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| Impact of Pentoxifylline Administration on the Modulation of Hyporesponsiveness to Erythropoietin Stimulating Agents in Hemodialysis Patients[NCT03800433] | Early Phase 1 | 46 participants (Anticipated) | Interventional | 2019-10-31 | Not yet recruiting | ||
| Is Hepcidin a Possible Contributor to Impaired Iron Mobilization and Anaemia in Hepatitis C Patients Treated With Pegylated Interferon Alpha and Ribavirin Therapy? A Pilot Study[NCT01726400] | 15 participants (Actual) | Observational | 2012-12-31 | Completed | |||
| Double-Blind, Placebo-Controlled, Randomised Trial Of Alpha-Tocopherol And Oxpentifylline In Patients With Radiation Fibrosis[NCT00022204] | Phase 2 | 0 participants | Interventional | 2000-01-31 | Completed | ||
| Development of Radiation Fibrosis in Patients Treated With Pentoxyphylline and Vitamin E: a Prospective Randomized Study[NCT00583700] | Phase 2 | 54 participants (Actual) | Interventional | 2003-02-28 | Completed | ||
| Non-invasive Measurement of Microvascular Blood Flow During Mild External Compression of the Leg[NCT01804478] | 20 participants (Actual) | Interventional | 2005-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A primary outcome of interest is the composite Subjective, Objective, Management, and Analytic (SOMA) score at 18-month follow-up visit. Maximum score is 45, with a score of 0 being ideal and representing no treatment-related side effects at the study visit. (NCT00583700)
Timeframe: 18 month post-treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Control Arm | 1.59 |
| Intervention: Pentoxifylline & Vitamin E | 1.0 |
"Tissue compliance meter measurements of the treated breast compared to the non-treated breast were obtained at 18 months post-radiation therapy. Tissue compliance simply means how soft and pliable the breast tissue is when force is applied to it.~One physician would hold the tissue compliance meter (TCM) against the participant's skin. A standard amount of force would be applied. A second physician would read the displacement scale for a specific set of areas on the breast. The range of the scale was 0 to 60 milimeters (mm). The physician's were blineded to the participant's intervention at the time of measurement.~The final value is the difference between the untreated and the treated breast [untreated - treated]. The range of these differences was -3.3 to 7.0 mm." (NCT00583700)
Timeframe: 18 months post-treatment
| Intervention | milimeters (mm) (Mean) |
|---|---|
| Control Arm | 2.10 |
| Intervention: Pentoxifylline & Vitamin E | 0.88 |
22 reviews available for pentoxifylline and Chronic Disease
| Article | Year |
|---|---|
[Pentoxifylline old drug or new hope for nephrology?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Cytokines; Humans; Kidney Diseases; Pento | 2008 |
Immunological mechanisms of pentoxifylline in chronic heart failure.
Topics: Chronic Disease; Heart Failure; Humans; Immunologic Factors; Pentoxifylline; Phosphodiesterase Inhib | 2009 |
Progress toward novel treatments for chronic kidney disease.
Topics: Amides; Anticoagulants; Antihypertensive Agents; Bicarbonates; Chronic Disease; Enzyme Inhibitors; F | 2010 |
Pharmacological treatment in patients with C4, C5 and C6 venous disease.
Topics: Calcium Dobesilate; Cardiology; Chronic Disease; Compression Bandages; Drug Therapy; Flavonoids; Hum | 2010 |
Medical and surgical therapy for advanced chronic venous insufficiency.
Topics: Bandages; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Leg | 2010 |
A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria.
Topics: Animals; Chronic Disease; Diabetic Nephropathies; Disease Progression; Humans; Kidney Diseases; Kidn | 2011 |
Pentoxifylline for endometriosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Endometriosis; Female; Humans; Immunologic | 2012 |
Perinatal immunomodulation.
Topics: Adjuvants, Immunologic; Chronic Disease; Cromolyn Sodium; Female; Glucocorticoids; Hematopoietic Cel | 2002 |
Deleterious effects of white cells in the course of skin damage in CVI.
Topics: Alprostadil; Cell Adhesion Molecules; Chronic Disease; Humans; Iloprost; Leg Ulcer; Leukocytes; Neut | 2002 |
Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Brain Diseases; Chronic Disease; Cytokines; Humans | 2004 |
Post-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review.
Topics: Abnormalities, Radiation-Induced; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; A | 2004 |
[The modern view on the role of inflammatory factors in chronic heart failure and possibilities of pharmacological modification].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory | 2003 |
Pentoxyfylline in and prevention and treatment of chronic lung disease.
Topics: Chronic Disease; Enzyme Inhibitors; Humans; Infant, Newborn; Lung Diseases; Pentoxifylline; Randomiz | 2004 |
Venous ulcers: pathophysiology and treatment options.
Topics: Anti-Inflammatory Agents; Aspirin; Bandages; Chronic Disease; Debridement; Diosmin; Growth Substance | 2005 |
[The use of pentoxyphylline in the treatment of patients with chronic obliterative diseases of lower limb arteries].
Topics: Administration, Oral; Arterial Occlusive Diseases; Blood Cells; Chronic Disease; Controlled Clinical | 2005 |
Evaluation and treatment of leg ulcers associated with chronic venous insufficiency.
Topics: Chronic Disease; Humans; Laser Therapy; Leg Ulcer; Pentoxifylline; Stockings, Compression; Vasodilat | 2007 |
[Tinnitus--classification, causes, diagnosis, treatment and prognosis].
Topics: Acute Disease; Adaptation, Physiological; Administration, Oral; Anti-Inflammatory Agents; Audiometry | 2004 |
Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review.
Topics: Abdominal Neoplasms; Acute Disease; Chronic Disease; Combined Modality Therapy; Controlled Clinical | 2008 |
[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Chronic Disease; Drug Therapy, Combination; Fe | 1995 |
[Conservative therapy of chronic venous insufficiency].
Topics: Bandages; Chronic Disease; Combined Modality Therapy; Fibrinolytic Agents; Humans; Life Style; Pento | 1992 |
Pentoxifylline as adjunctive therapy in leg ulcer management.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Aged, 80 and over; Blood Cells; Chronic Disease; Female; Human | 1991 |
[Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
Topics: Arterial Occlusive Diseases; Chronic Disease; Combined Modality Therapy; Hemodilution; Humans; Pento | 1986 |
23 trials available for pentoxifylline and Chronic Disease
| Article | Year |
|---|---|
Ginkgo biloba extract EGb 761
Topics: Adult; Aged; Chronic Disease; Czech Republic; Double-Blind Method; Female; Ginkgo biloba; Humans; Ma | 2018 |
Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Chemokine CCL2; | 2008 |
Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chronic Dis | 2009 |
A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.
Topics: Adult; Chronic Disease; Coitus; Delayed-Action Preparations; Double-Blind Method; Humans; Male; Midd | 2010 |
Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
Topics: Anemia, Iron-Deficiency; Biomarkers; Chronic Disease; Ferritins; Hematinics; Hemoglobins; Humans; In | 2010 |
Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
Topics: Anemia, Iron-Deficiency; Biomarkers; Chronic Disease; Ferritins; Hematinics; Hemoglobins; Humans; In | 2010 |
Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
Topics: Anemia, Iron-Deficiency; Biomarkers; Chronic Disease; Ferritins; Hematinics; Hemoglobins; Humans; In | 2010 |
Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
Topics: Anemia, Iron-Deficiency; Biomarkers; Chronic Disease; Ferritins; Hematinics; Hemoglobins; Humans; In | 2010 |
Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chronic Disease; Combined Modality Therapy; Confid | 2004 |
Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chronic Disease; Combined Modality Therapy; Confid | 2004 |
Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chronic Disease; Combined Modality Therapy; Confid | 2004 |
Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chronic Disease; Combined Modality Therapy; Confid | 2004 |
Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.
Topics: Adult; Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blind Me | 1982 |
Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; E | 1982 |
Oral pentoxifylline is not effective in the treatment of recalcitrant chronic hand eczema.
Topics: Administration, Oral; Chronic Disease; Eczema; Humans; Pentoxifylline; Pilot Projects; Treatment Fai | 1995 |
Intravenous pentoxifylline for the treatment of chronic critical limb ischaemia. The European Study Group.
Topics: Aged; Analgesics; Chronic Disease; Double-Blind Method; Female; Humans; Infusions, Intravenous; Isch | 1995 |
Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: preliminary observations.
Topics: Administration, Oral; Adolescent; Adult; Bronchitis; Bronchoalveolar Lavage Fluid; Child; Chronic Di | 1994 |
Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Cells, Cultured; Chronic Disease; Crohn Disease; Drug Therapy, Comb | 1997 |
Perceived health in a randomised trial of treatment for chronic venous ulceration.
Topics: Adult; Aged; Aged, 80 and over; Bandages; Chronic Disease; Female; Health Status; Humans; Male; Midd | 1999 |
The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxifylline ('Trental' 400).
Topics: Administration, Oral; Aged; Cerebrovascular Disorders; Chronic Disease; Clinical Trials as Topic; Do | 1979 |
[The effect of pentoxifylline on liver perfusion: a comparative study in patients with liver diseases and in normal subjects, using 198Au-colloid-scintigraphy (author's transl)].
Topics: Adult; Aged; Chronic Disease; Female; Hepatitis; Humans; Liver; Liver Circulation; Liver Cirrhosis; | 1979 |
Treatment of chronic cerebrovascular disease in elderly patients with pentoxifylline.
Topics: Aged; Cerebrovascular Disorders; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle | 1992 |
Pentoxifylline in the treatment of venous leg ulcers.
Topics: Aged; Bandages; Chemotherapy, Adjuvant; Chronic Disease; Double-Blind Method; Female; Humans; Leg Ul | 1992 |
Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Electr | 1989 |
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
Topics: Aged; Alprostadil; Arterial Occlusive Diseases; Chronic Disease; Follow-Up Studies; Humans; Multicen | 1989 |
Therapy of atherosclerotic arteriopathy of lower limbs. Aspects and results.
Topics: Acute Disease; Arteriosclerosis; Chronic Disease; Clinical Trials as Topic; Glycosaminoglycans; Hepa | 1985 |
A controlled study on the effect of pentoxifylline and an ergot alkaloid derivative on regional cerebral blood flow in patients with chronic cerebrovascular disease.
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Clinical Trials as Topic; E | 1988 |
Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
Topics: Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Exercise Test; Humans; Inter | 1987 |
Blood flow properties and walking performance in chronic arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Blood; Blood Circulation; Blood Viscosity; Chronic Disease; Clini | 1985 |
53 other studies available for pentoxifylline and Chronic Disease
| Article | Year |
|---|---|
Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid.
Topics: Adult; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Chronic Disease; Cicatrix; Clobetasol | 2018 |
Pentoxifylline ameliorates chronic stress/high-fat diet-induced vascular wall disease: the role of circulating endothelial progenitor cells.
Topics: AC133 Antigen; Animals; Aorta, Thoracic; Body Weight; Chronic Disease; Diet, High-Fat; Endothelial P | 2019 |
Multimodal therapy for chronic tinnitus.
Topics: Adult; Aged; Betahistine; Chronic Disease; Cinnarizine; Combined Modality Therapy; Dimenhydrinate; D | 2008 |
Inflammation in chronic heart failure: what is familiar, what is unfamiliar?
Topics: Anti-Inflammatory Agents; Chronic Disease; Heart Failure; Humans; Inflammation; Pentoxifylline; Tumo | 2009 |
Immunological mechanisms of pentoxifylline in chronic heart failure.
Topics: Anemia; Biomarkers; Chronic Disease; Heart Failure; Hemoglobins; Humans; Immunologic Factors; Pentox | 2009 |
[Role of pendoxifiline (PTX) in different and cute and chronic models of pain in rats].
Topics: Acute Disease; Animals; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Inflammation; | 2008 |
Effects of pentoxifylline during Schistosoma mansoni infection in Swiss mice: an analysis of worm burden, fecundity and liver histopathology.
Topics: Acute Disease; Animals; Chronic Disease; Female; Fertility; Granuloma; Liver; Male; Mice; Parasite E | 2010 |
[Intravenous laser irradiation of blood for the combined treatment of patients presenting with chronic sensorineural hearing loss].
Topics: Adult; Audiometry; Blood; Chronic Disease; Female; Hearing; Hearing Loss, Sensorineural; Humans; Inj | 2011 |
[Endothelium-protective effects of vinpocetine, pentoxifylline and enalapril in patients with chronic brain ischemia].
Topics: Adult; Aged; Antihypertensive Agents; Brain Ischemia; Case-Control Studies; Cerebrovascular Circulat | 2011 |
Pentoxifylline acutely reduces protein catabolism in chronically uremic patients.
Topics: Amino Acids; Carbon Dioxide; Carbon Isotopes; Chronic Disease; Drug Administration Schedule; Female; | 2002 |
Pentoxifylline reduces acute lung injury in chronic endotoxemia.
Topics: Animals; Bronchoalveolar Lavage Fluid; CD11b Antigen; Chronic Disease; Edema; Endotoxemia; Intercell | 2003 |
Case report: resolution of symptomatic epidural fibrosis following treatment with combined pentoxifylline-tocopherol.
Topics: Adult; Antioxidants; Chronic Disease; Drug Therapy, Combination; Fibrosis; Humans; Intervertebral Di | 2004 |
Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs.
Topics: Animals; Chronic Disease; Humans; Inflammation; Lipids; Pentoxifylline; Rats; Tumor Necrosis Factor- | 2004 |
[A new method of treatment of chronic ischemia of extremities with the primary lesion of the distal arterial bed (experimental-clinical investigation)].
Topics: Aged; Animals; Anti-Bacterial Agents; Anticoagulants; Arteriosclerosis; Catheterization; Chronic Dis | 2004 |
Proposal to use pentoxifylline and Lyprinol therapy for chronic inflammatory diseases.
Topics: Chronic Disease; Drug Therapy, Combination; Humans; Inflammation; Lipids; Pentoxifylline; Tumor Necr | 2005 |
Comprehensive decision-analytic model and Bayesian value-of-information analysis: pentoxifylline in the treatment of chronic venous leg ulcers.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bayes Theorem; Chronic Disease; Cost-Benefit Analysis | 2006 |
Resolution of chronic pain and fingertip ulceration due to hand-arm vibration syndrome following combination pharmacotherapy.
Topics: Chronic Disease; Drug Therapy, Combination; Hand-Arm Vibration Syndrome; Humans; Male; Middle Aged; | 2007 |
[The change of the patients organism immune reactivity in complicated chronic pancreatitis while performance of complex treatment].
Topics: Adult; Antigens, CD; Chronic Disease; Combined Modality Therapy; Female; Free Radical Scavengers; Hu | 2007 |
Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery.
Topics: Animals; Apoptosis; Chronic Disease; Disease Models, Animal; Endarterectomy; Endothelial Cells; Free | 2008 |
[Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Topics: Cholesterol; Chronic Disease; Erythrocytes; Humans; Intracranial Arteriosclerosis; Pentoxifylline; P | 1983 |
[Clinical and treatment characteristics of psoriasis patients with carbohydrate metabolic disorders].
Topics: Adult; Aged; Blood Glucose; Carbohydrates; Chronic Disease; Diabetes Mellitus; Drug Therapy, Combina | 1983 |
Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Coagulation; Blood Flow Velocity; Chronic | 1981 |
[Clinical study of the cerebrovascular action of pentoxifylline].
Topics: Acute Disease; Adult; Arteriosclerosis; Brain Ischemia; Cerebrovascular Disorders; Chronic Disease; | 1982 |
Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
Topics: Adenosine Triphosphate; Arterial Occlusive Diseases; Blood Coagulation Disorders; Chronic Disease; E | 1981 |
Effect of pentoxifylline on cerebral blood flow in patients with chronic cerebrovascular disease.
Topics: Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Female; Humans; Male; | 1981 |
[The effect of kavinton, trental, sermion and kurantil on the blood flow rate in individual segments of the cerebral arteries].
Topics: Blood Flow Velocity; Cerebral Arteries; Chronic Disease; Dipyridamole; Drug Evaluation; Female; Huma | 1994 |
[The clinical picture, diagnosis and treatment of the corpus-isthmus location of uterine endometriosis interna].
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Endometriosis; Endometrium; Fat Emulsions, Intrav | 1993 |
Chronic balanitis with palisading granuloma: an atypical genital localization of necrobiosis lipoidica responsive to pentoxifylline.
Topics: Aged; Aged, 80 and over; Balanitis; Chronic Disease; Diagnosis, Differential; Humans; Male; Necrobio | 1994 |
Pentoxifylline therapy for chronic claudication: are patients dependent on therapy?
Topics: Aged; Chronic Disease; Exercise Test; Follow-Up Studies; Humans; Intermittent Claudication; Pentoxif | 1994 |
Pentoxifylline treatment of persistent pulmonary hypertension of newborn.
Topics: Chronic Disease; Humans; Hypertension, Pulmonary; Infant, Newborn; Infant, Premature, Diseases; Pent | 1993 |
Hemorheologic approach in the treatment of diabetic foot ulcers.
Topics: Blood Flow Velocity; Chronic Disease; Diabetes Mellitus; Drug Evaluation; Follow-Up Studies; Foot; F | 1993 |
[Treatment of trophic ulcers of the lower extremities with Trental-400].
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Chronic Disease; Drug Evaluation; Human | 1996 |
[Lymphotropic therapy with trental in the treatment of chronic herpetic stomatitis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibody Formation; Antiviral Agents; Chronic Disease; Dr | 1997 |
[Disorders of the blood microcirculation in patients with suppurative-necrotic complications in diabetes mellitus and the approaches to their correction].
Topics: Adult; Aged; Chronic Disease; Combined Modality Therapy; Conjunctiva; Diabetes Mellitus, Type 1; Dia | 1998 |
Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology.
Topics: Animals; Chemokine CCL2; Chronic Disease; Disease Progression; Female; Interferon-gamma; Lung; Mice; | 2001 |
Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis.
Topics: Administration, Oral; Animals; Cholestasis; Chronic Disease; Collagen; Cytokines; DNA Probes; DNA, C | 2002 |
[Chronic liver diseases. The nihilism has gone].
Topics: Amantadine; Antioxidants; Antiviral Agents; Chronic Disease; Dipeptides; Drug Therapy, Combination; | 2001 |
[Viscosity of blood and sensorineural hearing loss (author's transl)].
Topics: Acute Disease; Audiometry; Blood Viscosity; Capillaries; Chronic Disease; Erythrocytes; Hearing Diso | 1977 |
[Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation; Blood Platelets; Chronic Disease; Femal | 1979 |
[Drug therapy of chronic tissue ischemia with improvement of microcirculation].
Topics: Adult; Blood Vessel Prosthesis; Chronic Disease; Extremities; Humans; Ischemia; Ischemic Attack, Tra | 1978 |
[Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Topics: Aged; Arm; Arterial Occlusive Diseases; Blood Flow Velocity; Chronic Disease; Drug Evaluation; Femal | 1978 |
Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs.
Topics: Arterial Occlusive Diseases; Bencyclane; Blood Viscosity; Chronic Disease; Cycloheptanes; Humans; Pe | 1977 |
Intractable chronic furunculosis: prevention of recurrences with pentoxifylline.
Topics: Chronic Disease; Furunculosis; Humans; Male; Middle Aged; Pentoxifylline; Recurrence | 1992 |
[The effect of pathogenetic therapy on the expression of endogenous intoxication in patients with chronic glomerulonephritis].
Topics: Chronic Disease; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis; Heparin; Humans; M | 1992 |
Chronic leukocytoclastic vasculitis associated with polycythemia vera: effective control with pentoxifylline.
Topics: Chronic Disease; Humans; Leg; Male; Middle Aged; Pentoxifylline; Polycythemia Vera; Vasculitis, Leuk | 1992 |
Treatment of sickle cell leg ulcers with pentoxifylline.
Topics: Anemia, Sickle Cell; Chronic Disease; Humans; Leg Ulcer; Male; Middle Aged; Pentoxifylline; Recurren | 1990 |
[The blood rheological indices of patients with necrobiosis lipoidica].
Topics: Adult; Aged; Blood Viscosity; Chronic Disease; Erythrocyte Aggregation; Erythrocyte Deformability; F | 1989 |
[Effect of the long-term prophylactic use of trental on cerebral blood flow in diabetics].
Topics: Adult; Cerebrovascular Disorders; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Diabet | 1988 |
[Trial of the combined use of trental and solcoseryl in treating patients with chronic pancreatitis].
Topics: Actihaemyl; Adult; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male | 1988 |
[Pentoxifylline (Trental) in the treatment of chronic glomerulonephritis].
Topics: Adolescent; Adult; Chronic Disease; Drug Evaluation; Female; Glomerulonephritis; Humans; Hypertensio | 1986 |
[Effect of a course of pentoxifylline (trental) treatment on microcirculatory and central hemodynamic functions in chronic ischemic heart disease patients].
Topics: Adult; Capillary Permeability; Chronic Disease; Coronary Disease; Hemodynamics; Humans; Leg; Lymph; | 1985 |
[Conservative treatment of trophic leg ulcers with trental].
Topics: Adult; Aged; Chronic Disease; Drug Evaluation; Female; Humans; Male; Middle Aged; Pentoxifylline; Th | 1985 |
[Use of teonikol and trental in the combined treatment of patients with suppurative surgical infection and concomitant diabetes mellitus].
Topics: Chronic Disease; Conjunctiva; Diabetes Mellitus; Drug Therapy, Combination; Female; Hemodynamics; Hu | 1985 |